|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| FFELP Loans | ||||||||||||||||||||
| Assets and Liabilities of Consolidated Variable Interest Entities | ||||||||||||||||||||
| Private Education Loans | ||||||||||||||||||||
| Total loans, net | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Private Education Loans | ||||||||||||||||||||
| Total loans held for sale | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Goodwill and acquired intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Assets and Liabilities of Consolidated Variable Interest Entities | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Assets and Liabilities of Consolidated Variable Interest Entities | ||||||||||||||||||||
| Total short-term borrowings | ||||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||||
| Assets and Liabilities of Consolidated Variable Interest Entities | ||||||||||||||||||||
| Total long-term borrowings | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Net assets of consolidated variable interest entities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Series A Junior Participating Preferred Stock, par value $0.20 per share; 2 million shares authorized at December 31, 2021; no shares issued or outstanding | ||||||||||||||||||||
| Common stock, par value $0.01 per share, 1.125 billion shares authorized: 468 million and 467 million shares issued, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (net of tax expense of $4 and $1, respectively) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders' equity before treasury stock | ||||||||||||||||||||
| Less: Common stock held in treasury at cost: 374 million and 371 million shares, respectively | ||||||||||||||||||||
| Total Navient Corporation stockholders’ equity | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
